Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Hematologic
N/A
Both
Bone Marrow/Stem Cell Transplant
Not Available
Kassim, Adetola
National
Vanderbilt University
10-20-2011
Multi-ctr Access & Distr. for Unlic. Cryopreserved CBU's Tnspl. Ped & Adlt w/ Hema. Malignancies
Other
VICCBMT1158
NCT01351545

Eligibility

0 Years
BOTH
NO
Inclusion Criteria:

Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment

Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment

Pediatric and adult patients of any age



Exclusion Criteria:

Patients who are receiving only licensed CBUs

Cord blood transplant recipients at international transplant centers

Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)

Patients whose selected unlicensed CBU(s) will be more than minimally manipulated

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: